Product finder

recomCLIA Borrelia

High-performance Borrelia serology for routine use
Fast. Automated. Precise – for the highest standards in routine diagnostics on the KleeYa®
  1. /
  2. Products & Automation
  3. /
  4. Product finder

The Mikrogen recomCLIA Borrelia tests rely on state-of-the-art quantitative in vitro chemiluminescence immunoassays (CLIA), equipped with recombinantly produced, highly specific, and immunodominant Borrelia antigens. They enable the reliable detection of IgG and IgM antibodies against all medically relevant pathogens of Lyme disease (Borrelia burgdorferi sensu lato complex), including B. burgdorferi sensu stricto, B. afzelii, B. garinii, and B. bavariensis.

The recomCLIA Borrelia Assay is the ideal choice for screening and diagnostic support in cases of suspected Borrelia infections – always in conjunction with other laboratory and clinical findings.

Our product range for you

recomCLIA Borrelia IgM
Reagents for 100 determinations
 Article no.: 74205 Request

recomCLIA Control Set Borrelia IgG
Reagents for 2x50 determinations
 Article no.: 74202 Request

recomCLIA Control Set Borrelia IgM
Reagents for 2x50 determinations
 Article no.: 74203 Request

recomCLIA Sample Diluent A
2x200 sample dilutions
 Article no.: 10120 Request

Why recomCLIA Borrelia

  • State-of-the-art CLIA technology – fast, safe, precise
  • Seamlessly compatible with the KleeYa® high-throughput system (random access)
  • Quantitative IgG or IgM detection for maximum result precision and reliability
  • Highest specificity and sensitivity based on highly purified, recombinant antigens
  • Highest measurement accuracy and reliable calibration with long-term stability
  • Coverage of all relevant Borrelia species in one test
  • LIS/middleware connection with bidirectional communication
  • IVDR-compliant and CE-marked
Sample matrixSerum, plasma
Sample volumeIgG: 13µl | IgM: 22µl (plus max. 150 µl dead volume in the device)
Sample Ttroughputup to 120 tests/h

Sensitivity IgG/IgM total:

 

 

 

Erythema migrans: 92%

Neuroborreliose: 98%

Arthritis: 100%

ACA: 100%

Specificity:IgG: 100% | IgM: 94,7%
Stability:12 Month
Calibration:every 14 days
  

Flexible. Compatible. Efficient.

CLIA assay for open random access testing platform for up to 16 parallel assays with up to 120 tests/hour.

Simple. Fast. Secure.

Less than 10 minutes of hands-on time per day, first test result after 30 minutes, direct data transfer to the LIS

Ideal for...

Laboratories focusing on throughput, efficiency, and reproducibility.